Results 221 to 230 of about 3,681,465 (347)

Cardiovascular Mortality in Incarcerated Populations: An Example of Health Inequalities Within Health Inequalities

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Benjamin J. Gray, Stephanie E. Perrett
doaj   +1 more source

Meal plan inclusions and exclusions in the inpatient, outpatient and community setting for adolescent and adult eating disorder care: a scoping review. [PDF]

J Eat Disord
Bendall C, Winderlich J, Anderson A, Caughey M, Hoy J, Coleman J, Bennett CJ.   +6 more
europepmc   +1 more source

The Importance of Diversity and Inclusion in the Healthcare Workforce.

Journal of the National Medical Association, 2020
F. C. Stanford
semanticscholar   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Disability inclusion in the Brazilian health system: results of a health system assessment. [PDF]

Glob Health Action
Polack S, Delgado Ramos V, Sepúlveda Köptcke L, de Araujo Morais I, Reichenberger V, Scherer N, Veloso de Albuquerque MDS, Kuper H, Lyra TM, Moran de Brito CM.   +9 more
europepmc   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

A Dual-Transducer Approach for High-Resolution and High-Precision Shear Wave Elasticity Imaging. [PDF]

Sensors (Basel)
Liu J, Emelianov SY.
europepmc   +1 more source

The determinants of financial inclusion in Africa

, 2016
Alexandra Zins, L. Weill
semanticscholar   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Feeling left out in the Lunchroom: Neural mechanisms of ostracism vary across adolescence. [PDF]

Dev Cogn Neurosci
Nelson CM, Revilla R, Friedman NR, Xia M, Hudac CM.   +4 more
europepmc   +1 more source